Go Deep
Merck KGaA
Merck KGaA Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,664 | 26.5 | 2.11 | 0.41 | 15,402.33 |
| Oct 2026 | 19,662 | 26.5 | 2.11 | 0.41 | 15,369.46 |
| Oct 2026 | 19,578 | 26.9 | 2.14 | 0.41 | 15,587.73 |
| Oct 2026 | 19,748 | 26.1 | 2.08 | 0.41 | 15,106.53 |
| Oct 2026 | 19,580 | 26.9 | 2.14 | 0.41 | 15,531.28 |
Merck KGaA Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | — | 5,134,000,000.0 | 5,249,000,000.0 | 5,318,000,000.0 |
| Net Profit | — | 659,000,000.0 | 319,000,000.0 | 902,000,000.0 |
| EPS | 1.1 | 1.5 | — | 2.1 |
Merck KGaA Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 21,102,000,000.0 | 21,156,000,000.0 | 20,993,000,000.0 | 22,232,000,000.0 |
| Net Profit | 2,608,000,000.0 | 2,777,000,000.0 | 2,824,000,000.0 | 3,326,000,000.0 |
| EPS | 6.0 | 6.4 | 6.5 | 7.7 |
Merck KGaA Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 51,527,000,000.0 | 51,596,000,000.0 | 48,495,000,000.0 | 48,535,000,000.0 | — |
| Total Liabilities | 22,867,000,000.0 | 21,607,000,000.0 | 21,740,000,000.0 | 22,530,000,000.0 | — |
| Total Equity | 28,592,000,000.0 | 29,914,000,000.0 | 26,680,000,000.0 | 25,927,000,000.0 | — |
Owes vs Owns
Merck KGaA owed €0.44 for every €1 it owned in Mar 2026, down from €0.46 in Dec 2022.
| Period | Mar 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.44× | 0.44× | 0.42× | 0.45× | 0.46× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Merck KGaA Assets & Liabilities Breakdown (EUR millions)
What it owns — Dec 2025
Cash & short-term investments 5.7%Receivables 7.7%Inventory 8.9%Fixed assets (tangible) 19.3%Intangible assets 49.7%Other assets 8.8%
How it's funded — Dec 2025
Short-term debt 2.1%Long-term debt 19.8%Payables 2.8%Other liabilities 19.7%Shareholders' equity 55.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2,925.0 | 2,708.0 | 2,009.0 | 1,642.0 |
| Receivables | 3,947.0 | 3,947.0 | 4,004.0 | 4,114.0 |
| Inventory | 4,562.0 | 4,484.0 | 4,637.0 | 4,632.0 |
| Fixed assets (tangible) | 9,940.0 | 10,025.0 | 9,056.0 | 8,204.0 |
| Intangible assets | 25,595.0 | 25,458.0 | 24,397.0 | 25,723.0 |
| Long-term investments | 3.0 | 3.0 | 3.0 | 3.0 |
| Other assets | 4,555.0 | 4,971.0 | 4,389.0 | 4,217.0 |
| Liabilities & equity | ||||
| Short-term debt | 1,098.0 | 3,136.0 | 503.0 | 1,073.0 |
| Long-term debt | 10,206.0 | 6,373.0 | 8,846.0 | 8,834.0 |
| Payables | 1,422.0 | 1,502.0 | 1,770.0 | 1,596.0 |
| Other liabilities | 10,141.0 | 10,596.0 | 10,621.0 | 11,027.0 |
| Shareholders' equity | 28,660.0 | 29,989.0 | 26,755.0 | 26,005.0 |
| Net tangible assets | 2,997.0 | 4,456.0 | 2,283.0 | 204.0 |
Merck KGaA Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 3,932,000,000.0 | 4,586,000,000.0 | 3,784,000,000.0 | 4,259,000,000.0 | — |
| Investing Activities | -4,261,000,000.0 | -3,050,000,000.0 | -1,892,000,000.0 | -2,743,000,000.0 | — |
| Financing Activities | 628,000,000.0 | -985,000,000.0 | -1,732,000,000.0 | -1,555,000,000.0 | — |